Showing 20 of 136 recruiting trials for “fibrolamellar-hepatocellular-carcinoma”
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
RecruitingNCT06430983 ↗
Recurrent Liver Cancer: Reconceptualization and Reevaluation
Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC
🏥 Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started May 2024View details ↗
Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma
Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)
RecruitingNCT06342414 ↗
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)
RecruitingNCT06261047 ↗
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
👨⚕️ jibo yue, dorctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Mar 2024View details ↗
BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)
DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
👨⚕️ Marina Baretti, MD, SKCCC • Johns Hopkins Medical Institution📍 1 site📅 Started Feb 2024View details ↗
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
👨⚕️ Fabrizio Di Benedetto, University of Modena and Reggio Emilia📍 1 site📅 Started Feb 2024View details ↗
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
National Liver Cancer Screening Trial
👨⚕️ Amit Singal, MD, MS, University of Texas Southwestern Medical Center📍 18 sites📅 Started Dec 2023View details ↗
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC
RecruitingNCT05705219 ↗
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
👨⚕️ Ahmed El Kaffas, PhD, University of California, San Diego📍 3 sites📅 Started Dec 2023View details ↗
Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma
RecruitingNCT06117891 ↗
An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
Atezolizumab and Bevacizumab With Proton Radiotherapy for Unresectable Hepatocellular Carcinoma
Enrolling by InvitationNCT05429190 ↗
Validation of SMS Protocol for HCC Screening in High-risk Patients
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →